Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Is Single Point Hba1c a Reliable Predictor for Death in Severe Covid‑19? Publisher Pubmed



Hosamirudsari H1 ; Alimohamadi Y2 ; Akrami M3 ; Zahra M1 ; Faraji N4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Infectious Diseases, Baharloo Hospital, Railway Square, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Health Research Center, Life Style Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran
  3. 3. Department of Anesthesiology, Baharloo Hospital, Railway Square, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Department of Internal Medicine, Baharloo Hospital, Railway Square, Tehran University of Medical Sciences, Tehran, Iran

Source: Journal of Preventive Medicine and Hygiene Published:2023


Abstract

Introduction. The severity of COVID‑19 infection is affected by Results. 165 COVID‑19 cases were included in this study; 126 several risk factors such as Diabetes Mellitus (DM). The current (76.4%) of which were severe cases. 89 (53.9%) patients were study aimed to determine the effect of single‑point HbA1c on the male, with a mean age of 59.89 ± 16.59 years. Severe COVID‑19 severity and mortality of hospitalized COVID‑19 patients. patients were more prone to a longer hospital stay, and a higher Methods. This cross‑sectional study was conducted among hospi‑ level of inflammatory mediators, compared to the moderate talized moderate and severe COVID‑19 patients in Baharloo Hos‑ COVID‑19 patients (p < 0.05). No significant association was pital in Iran between December 23rd and February 23rd, 2021. found between single point HbA1c, FBS, and severity and mortal‑ The patients have been diagnosed by Polymerase Chain Reac‑ ity of COVID‑19 cases (p > 0.05). tion (PCR) and Chest Computed Tomography (CT) imaging as Conclusions. Single point HbA1c was not a reliable mediator COVID‑19. Demographic data, clinical presentation, laboratory for the prediction of severity or death in hospitalized COVID‑19 results, and treatments along with the HbA1c data were included. patients. © Copyright by Pacini Editore Srl, Pisa, Italy.